换一批Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.
第一作者：
Andree,Yeramian
第一单位：
Pathology Group, Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB-Lleida, Lleida, Spain.
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);硼酸化物(Boronic Acids);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);色酮类(Chromones);人类(Humans);吲哚类(Indoles);黑色素瘤(Melanoma);吗啉类(Morpholines);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);吡嗪类(Pyrazines);吡咯类(Pyrroles);RNA, 小分子干扰(RNA, Small Interfering);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);受体, 血小板源生长因子α(Receptor, Platelet-Derived Growth Factor alpha);信号传导(Signal Transduction);血管内皮生长因子受体2(Vascular Endothelial Growth Factor Receptor-2)
DOI
10.1002/ijc.26096
PMID
21445974
发布时间
2018-12-01
- 浏览126
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
